0.65 (-%)
As of Oct 31, 2024
Source:
We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. We are a pioneer company in the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patients overall survival.
Country | United States |
Headquarters | berkeley heights, new jersey |
Phone Number | 908-517-7330 |
Industry | manufacturing |
CEO | Spiro Rombotis |
Website | www.cyclacel.com |